Legislator Giurisprudenza & Legislazione
II UK 243/03 Generato dall'IA

Supreme Court dismisses appeal; Health Fund cannot deny drug costs based on age or self-assessment of treatment validity.

Numero d'incarto II UK 243/03
Autorità giudiziaria
Giurisdizione Polonia (PL)
Data della decisione
Esito del giudizio Respinto (Dismissed)

Sintesi Legislator

Generato dall'IA

The Supreme Court dismissed the National Health Fund's cassation appeal regarding a refusal to reimburse medication costs for a minor with multiple sclerosis. The Fund argued that the drug Betaferon was only tested on adults, while the patient and lower courts contended the treatment was medically necessary and effective. The court ruled that the Health Fund lacks authority to question the medical validity of a prescribed treatment or deny coverage based on arbitrary age restrictions, thereby upholding the patient's right to equal access to care.

Regesto Legislator

Generato dall'IA

Art. 39 ust. 1 ustawy o powszechnym ubezpieczeniu zdrowotnym; Art. 68 ust. 2 Konstytucji RP: The Health Fund cannot refuse reimbursement for prescribed medication by questioning the medical validity of the treatment method or by applying arbitrary age-based restrictions that violate the principle of equal access to healthcare.

Parole chiave

Generato dall'IA
Health Fund reimbursement multiple sclerosis treatment age-based restrictions medical necessity principle of equality cassation appeal healthcare access

Disposizioni normative citate

Generato dall'IA
Art. 39 ust. 1 ustawy z dnia 6 lutego 1997 r. o powszechnym ubezpieczeniu zdrowotnym
Art. 68 ust. 2 Konstytucji RP
Art. 31 ust. 2 ustawy z dnia 6 lutego 1997 r. o powszechnym ubezpieczeniu zdrowotnym
Art. 7 ust. 7 ustawy z dnia 6 lutego 1997 r. o powszechnym ubezpieczeniu zdrowotnym
Art. 61 ust. 1 ustawy z dnia 6 lutego 1997 r. o powszechnym ubezpieczeniu zdrowotnym
Art. 39312 k.p.c.
art. 68 ust. 2 Konstytucji RP
art. 3931 k.p.c
art. 316 k.p.c
art. 278 k.p.c

Ti chiedi come si applica questa sentenza alla tua fattispecie?

Analizza questa decisione insieme alla legislazione federale e cantonale, ai commentari e alla giurisprudenza successiva in Legislator AI.

Apri in Legislator →

Testo completo